Positive day clear hepatitis B class 1 new drugs were approved clinically.

On August 25, CDE's official website revealed that the TQA3729 capsule, a new class 1 drug, had been approved clinically for the treatment of chronic hepatitis B.
from: CDE official website Zhengda Tianqing is the domestic hepatitis B field leader, has been listed more than 10 liver disease products.
the heavy drug Entecavir dispersion tablets for the domestic first imitation, hepatitis B treatment of first-line medication.
, according to tianqing official website, there are currently 1 drug declared clinical in the field of liver health, 5 drugs in clinical trial stage, 4 drugs reported.
Insight database shows that as of August 25, another new hepatitis B drug, TQ-A3334, is currently undergoing 3 clinical trials, with the fastest progress to Phase 2 clinical trials.
from: Insight Database () According to insight database, there are currently new drugs in the field of anti-infection, anti-tumor, endocrinology and other fields in the study of products pipeline as shown in the following illustration.
from: Insight Database ()